I do agree with nee cdc director that all positives should be treated as a new variant
Pretty good numbers, though. Keep in mind the flu shots are about 55% effective. The important thing is prevention of very severe disease and death. It appears that the J&J vaccines does that. Still need to sort through data.
Good to have options.
I agree with you that it’s premature to treat all new positive cases as if they’re a new variant. The dominant variant right now is still the `Italian’ variant for lack of a better word. Will the B.1.1.7 or `U.K.’ variant become dominant like it has in Britain, Portugal, and Israel? Perhaps. We do need to be vigilant, as the three new variants causing the most trouble are here in the U.S. and are spreading. All three will cause reductions in vaccine efficacy. BUT, thus far, that reduction is not dramatic.
I do understand your point. But I suspect that anyone who had a choice between 90+ and 70+ effectiveness would choose the former. Maybe it is ok as a backup down the road but I would not make the choice.
Numbers in Massachusetts have improved in terms of cases, test positivity, and hospitalizations. It’s not a dramatic decline. But it is progress.
Nationwide the hospitalizations continue to fall, which is good.
But, I’m still seeing too many new cases nationwide. Today will mark the 4th straight day of significant growth in case numbers, after a steady decline for 14 days. Test positivity is around 9%. Too high for comfort. Also, allows for mutant versions of virus to develop.
I didn’t make myself clear. I do agree we should treat all nee cases as if they were a new variant and test accordingly.
Chris Murray runs what is perhaps the best known model on Covid-19 in the U.S. It’s also turned out to be the most accurate thus far. I was skeptical back in the spring. But, I have since changed my mind. Here’s Murray on the impact of the new variants: https://twitter.com/IHME_UW/status/1355301573086179332
C-19 for 1-30 is ready…
Comments are closed.
Your no-hype southeastern New England weather blog!
I know they are pushing the J&J but 72% in the US and 66% against new variant do not impress me.
https://www.reuters.com/article/health-coronavirus-vaccines-johnsonjohns/jj-covid-19-vaccine-is-72-effective-in-the-u-s-and-66-overall-in-large-trial-idUSL1N2K406P
I do agree with nee cdc director that all positives should be treated as a new variant
Pretty good numbers, though. Keep in mind the flu shots are about 55% effective. The important thing is prevention of very severe disease and death. It appears that the J&J vaccines does that. Still need to sort through data.
Good to have options.
I agree with you that it’s premature to treat all new positive cases as if they’re a new variant. The dominant variant right now is still the `Italian’ variant for lack of a better word. Will the B.1.1.7 or `U.K.’ variant become dominant like it has in Britain, Portugal, and Israel? Perhaps. We do need to be vigilant, as the three new variants causing the most trouble are here in the U.S. and are spreading. All three will cause reductions in vaccine efficacy. BUT, thus far, that reduction is not dramatic.
I do understand your point. But I suspect that anyone who had a choice between 90+ and 70+ effectiveness would choose the former. Maybe it is ok as a backup down the road but I would not make the choice.
Numbers in Massachusetts have improved in terms of cases, test positivity, and hospitalizations. It’s not a dramatic decline. But it is progress.
Nationwide the hospitalizations continue to fall, which is good.
But, I’m still seeing too many new cases nationwide. Today will mark the 4th straight day of significant growth in case numbers, after a steady decline for 14 days. Test positivity is around 9%. Too high for comfort. Also, allows for mutant versions of virus to develop.
I didn’t make myself clear. I do agree we should treat all nee cases as if they were a new variant and test accordingly.
Chris Murray runs what is perhaps the best known model on Covid-19 in the U.S. It’s also turned out to be the most accurate thus far. I was skeptical back in the spring. But, I have since changed my mind. Here’s Murray on the impact of the new variants: https://twitter.com/IHME_UW/status/1355301573086179332
C-19 for 1-30 is ready…